Doctor: Pause of J&J vaccine could teach us lessons but hurt vulnerable populations
Published: April 15, 2021 4:53 PM EDT
Updated: April 15, 2021 5:26 PM EDT
Recommended
A decision on the future of the Johnson & Johnson vaccine could still be weeks away.
A CDC panel is trying to figure out the best way to handle resuming the use of the vaccine after a handful of people developed blood clots and low platelet counts.
The pause is meant to increase vaccine confidence and safety, but some fear it could harm the most vulnerable populations.
“The initial pause was a very sensible thing to do because there was a lot we needed to explore,” said Dr. Ross McKinney, chief scientific officer with the Association of American Medical Colleges.
Experts urge more research after blood clots reported from J&J vaccine
Published: April 15, 2021 5:42 PM EDT
Updated: April 15, 2021 6:12 PM EDT
Recommended
Doses of the Johnson & Johnson vaccine are still on temporary hold after dangerous blood clots were found exclusively in women. Experts are urging scientists to do more research so it doesn’t happen again.
“The CDC and the FDA are reviewing data involving six reports of a rare type of blood clot called cerebral venous sinus thrombosis or CVST – in combination with low levels of platelets in the blood, called thrombocytopenia, in women ages 18 to 48,” said Dr. Peter Marks, Ph.D., director of the Center for Biologics Evaluation and Research at the Food and Drug Administration.
The consensus: err on the side of caution and don’t rush anything.
For now, the J&J vaccine remains on pause after seven women developed stroke-like symptoms after getting the shot. One of them died.
“Confidence in this vaccine program and now the CDC is in grave, grave danger,” said Del Bigtree, CEO of the Informed Consent Action Network.
As national health experts debated the fate of the J&J vaccine, they heard passionate pleas from the public.
“We now have a vaccine that is just like the AstraZeneca vaccine in Europe – and I am honestly questioning the CDC,” Bigtree said.
Next steps for the Johnson & Johnson vaccine after CDC and FDA recommend halting use
Published: April 13, 2021 6:15 PM EDT
Updated: April 13, 2021 6:25 PM EDT
Recommended
After the discussion of safety, many wonder what the next steps are for this vaccine.
The CDC’s Advisory Committee on Immunization Practices will meet to discuss these rare side effects and the plan moving forward on Wednesday.
Adam Montella, Sr. is the Vice President for Planning and Analysis, The Olson Group, Ltd. “The top of the brain has three layers of protection. And in that one layer controls the drainage of the face in the brain,” Montella said.
Biden champions cancer research, treatment innovation in federal budget winknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from winknews.com Daily Mail and Mail on Sunday newspapers.